Celldex Therapeutics CLDX Interest income and other, net
Interest income and other, net at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's interest income and other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Celldex Therapeutics's interest income and other, net?
- Celldex Therapeutics (CLDX) reported interest income and other, net of $5.75M in Q1 2026.
- How has Celldex Therapeutics's interest income and other, net changed year-over-year?
- Celldex Therapeutics's interest income and other, net decreased by 35.7% year-over-year, from $8.94M to $5.75M.
- What is the long-term trend for Celldex Therapeutics's interest income and other, net?
- Over 4 years (2021 to 2025), Celldex Therapeutics's interest income and other, net has grown at a 174.3% compound annual growth rate (CAGR), from $505K to $28.61M.